Extracorporeal Membrane Oxygenation for COVID-19-associated Severe Acute Respiratory Distress Syndrome in Chile A Nationwide Incidence and Cohort Study
dc.contributor.author | Diaz, Rodrigo A. | |
dc.contributor.author | Graf, Jeronimo | |
dc.contributor.author | Zambrano, Jose M. | |
dc.contributor.author | Ruiz, Carolina | |
dc.contributor.author | Espinoza, Juan A. | |
dc.contributor.author | Bravo, Sebastian, I | |
dc.contributor.author | Salazar, Pablo A. | |
dc.contributor.author | Bahamondes, Juan C. | |
dc.contributor.author | Castillo, Luis B. | |
dc.contributor.author | Gajardo, Abraham I. J. | |
dc.contributor.author | Kursbaum, Andres | |
dc.contributor.author | Ferreira, Leonila L. | |
dc.contributor.author | Valenzuela, Josefa | |
dc.contributor.author | Castillo, Roberto E. | |
dc.contributor.author | Perez-Araos, Rodrigo A. | |
dc.contributor.author | Bravo, Marcela | |
dc.contributor.author | Aquevedo, Andres F. | |
dc.contributor.author | Gonzalez, Mauricio G. | |
dc.contributor.author | Pereira, Rodrigo | |
dc.contributor.author | Ortega, Leandro | |
dc.contributor.author | Santis, Cesar | |
dc.contributor.author | Fernandez, Paula A. | |
dc.contributor.author | Cortes, Vilma | |
dc.contributor.author | Cornejo, Rodrigo A. | |
dc.date.accessioned | 2025-01-20T22:14:19Z | |
dc.date.available | 2025-01-20T22:14:19Z | |
dc.date.issued | 2021 | |
dc.description.abstract | Rationale: The role of and needs for extracorporeal membrane oxygenation (ECMO) at a population level during the coronavirus disease (COVID-19) pandemic have not been completely established. | |
dc.description.abstract | Objectives: To identify the cumulative incidence of ECMO use in the first pandemic wave and to describe the Nationwide Chilean cohort of ECMO-supported patients with COVID-19. | |
dc.description.abstract | Methods: We conducted a population-based study from March 3 to August 31, 2020, using linked data from national agencies. The cumulative incidence of ECMO use and mortality risk of ECMO-supported patients were calculated and age standardized. In addition, a retrospective cohort analysis was performed. Outcomes were 90-day mortality after ECMO initiation, ECMO-associated complications, and hospital length of stay. Cox regression models were used to explore risk factors for mortality in a time-to-event analysis. | |
dc.description.abstract | Measurements and Main Results: Ninety-four patients with COVID-19 were supported with ECMO (0.42 per population of 100,000, 14.89 per 100,000 positive cases, and 1.2% of intubated patients with COVID-19); 85 were included in the cohort analysis, and the median age was 48 (interquartile range [IQR], 41-55) years, 83.5% were men, and 42.4% had obesity. The median number of pre-ECMO intubation days was 4 (IQR, 2-7), the median PaO2/FIO2 ratio was 86.8 (IQR, 64-99) mm Hg, 91.8% of patients were prone positioned, and 14 patients had refractory respiratory acidosis. Main complications were infections (70.6%), bleeding (38.8%), and thromboembolism (22.4%); 52 patients were discharged home, and 33 died. The hospital length of stay was a median of 50 (IQR, 24-69) days. Lower respiratory system compliance and higher driving pressure before ECMO initiation were associated with increased mortality. A duration of pre-ECMO intubation >10 days was not associated with mortality. | |
dc.description.abstract | Conclusions: Documenting nationwide ECMO needs may help in planning ECMOprovision for future COVID-19 pandemic waves. The 90-day mortality of the Chilean cohort of ECMO-supported patients with COVID-19 (38.8%) is comparable to that of previous reports. | |
dc.fuente.origen | WOS | |
dc.identifier.doi | 10.1164/rccm.202011-4166OC | |
dc.identifier.eissn | 1535-4970 | |
dc.identifier.issn | 1073-449X | |
dc.identifier.uri | https://doi.org/10.1164/rccm.202011-4166OC | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/94477 | |
dc.identifier.wosid | WOS:000674175600011 | |
dc.issue.numero | 1 | |
dc.language.iso | en | |
dc.pagina.final | 43 | |
dc.pagina.inicio | 34 | |
dc.revista | American journal of respiratory and critical care medicine | |
dc.rights | acceso restringido | |
dc.subject | extracorporeal membrane oxygenation | |
dc.subject | COVID-19 | |
dc.subject | severe acute respiratory distress syndrome | |
dc.subject | pandemic | |
dc.subject.ods | 03 Good Health and Well-being | |
dc.subject.odspa | 03 Salud y bienestar | |
dc.title | Extracorporeal Membrane Oxygenation for COVID-19-associated Severe Acute Respiratory Distress Syndrome in Chile A Nationwide Incidence and Cohort Study | |
dc.type | artículo | |
dc.volumen | 204 | |
sipa.index | WOS | |
sipa.trazabilidad | WOS;2025-01-12 |